{"cmr":"fr-cm-kg/XPAR/FR0012616852","since":null,"total":40,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-11-04","event_type":"newswire_release","title":"ABIONYX Pharma Signs a Strategic Partnership with Lille ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261103333309/en/ABIONYX-Pharma-Signs-a-Strategic-Partnership-with-Lille-University-HospitalBurn-Treatment-Center-and-Intensive-Care-Unitto-Explore-the-Potential-of-CER-001-in-Severe-Burn-Patients-at-High-Risk-for-Sepsis","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"O80LoX64uvfjNkPuz-Wae9WMvy77JYIG8irchrBxwPUXijxvZkcV7iVXkLwEq4N7jENhI4nr0SQ_4tGdOv5uDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-10-27","event_type":"newswire_release","title":"ABIONYX Pharma Finalizes the Structuring of Its CER-001 ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261026525078/en/ABIONYX-Pharma-Finalizes-the-Structuring-of-Its-CER-001-Bioproduction-Chain-Through-a-Strategic-Partnership-with-AXPLORA-Marking-a-Major-Milestone-Toward-Its-Potential-Commercialization","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"sSQLwdWOca9U2iVom7872HOgff2HdY5iHv3wu928UKJXjYMQn-UaLABYdLcXapKsru8h3OgG3hn5amtR84Y0Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-10-26","event_type":"newswire_release","title":"ABIONYX Pharma Finalizes the Structuring of Its CER-001 ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261026525078/en/ABIONYX-Pharma-Finalizes-the-Structuring-of-Its-CER-001-Bioproduction-Chain-Through-a-Strategic-Partnership-with-AXPLORA-Marking-a-Major-Milestone-Toward-Its-Potential-Commercialization","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0lgMvzGLZOBFngHLPeSY8MyzFQmvIfxxESbd08Q051ppbw6JrkYHzjdJ8-aVOW4Qz54SlHM14M9r4dRLOgC9AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-10-07","event_type":"newswire_release","title":"ABIONYX Pharma and OLON Enter Into Strategic ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261006736714/en/ABIONYX-Pharma-and-OLON-Enter-Into-Strategic-Manufacturing-Partnership-to-Prepare-CER-001-Biologic-for-Regulatory-Approval-and-Commercial-Supply","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"wzC6x_BP75dZGCBDReRKFCfV7tSmmoixXOBlK_0ZyDTHHrzJIDQ6HjMSYJ6TADu4AS1rsEOXuhdj1CaIDcPzCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-10-02","event_type":"newswire_release","title":"ABIONYX Pharma Announces the Settlement of an ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261001351326/en/ABIONYX-Pharma-Announces-the-Settlement-of-an-Anticipated-Amortization-Payment-in-Accordance-With-the-Terms-of-Its-Bonds-Financing-Agreement","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"X6ceDgZ9UZJUnXct9RFTWFnk6CAagAwVttJbsRqMYgALCws45MPhTuDP7Nr3AAnheZrrFIuVgoAFFslFNIrxDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-10-02","event_type":"newswire_release","title":"ABIONYX Pharma: Monthly Statement of Total Voting ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20261002544722/en/ABIONYX-Pharma-Monthly-Statement-of-Total-Voting-Rights-and-Shares-Forming-the-Companys-Share-Capital","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xrOahd4AQaUAVbf4sD7mHriCyyxzs-RevMpl9a6qGWuEKMJrhGLu8SrXMMNR_0Y0UXl1hQ42IGbP4H_JI1tuDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-09-11","event_type":"newswire_release","title":"ABIONYX Pharma Reaches Another Key Milestone in the ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260910938943/en/ABIONYX-Pharma-Reaches-Another-Key-Milestone-in-the-Industrialization-of-CER-001-by-Entering-into-a-Strategic-Partnership-with-TEXCELL-ABL-Diagnostics-for-the-Viral-Safety-and-Clearance-of-Biologics","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ReBuecBFBbfeiT74cNiaq-aLRHJ5-glmrhFyl9-BQMIjnVutbNapaEp2rneogtSPAMBbyxaUoQU_3OPaU0PsBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-09-10","event_type":"newswire_release","title":"ABIONYX Pharma Reaches Another Key Milestone in the ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260910938943/en/ABIONYX-Pharma-Reaches-Another-Key-Milestone-in-the-Industrialization-of-CER-001-by-Entering-into-a-Strategic-Partnership-with-TEXCELL-ABL-Diagnostics-for-the-Viral-Safety-and-Clearance-of-Biologics","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ShwddB2MEDv9ptWpI-BHVZkdENgJSn9_DHZOr0DFDm0X9x5Ptoja9stOCmHF3C1zu4yNvMj_8tf7RAj17Z2nDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-09-08","event_type":"major_holder","title":"ABIONYX Pharma: Monthly Statement of Total Voting Rights and ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260907152642/en/ABIONYX-Pharma-Monthly-Statement-of-Total-Voting-Rights-and-Shares-Forming-the-Companys-Share-Capital","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-s49SwkZKFN5_STAHq9qrzdJBKlnrfT9WtS5ORx6Lxs3rmueSDNBfC1TTqYfwbg2I9kcBxHiUpT57qtgkEKLCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-09-07","event_type":"major_holder","title":"ABIONYX Pharma: Monthly Statement of Total Voting Rights and ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260907152642/en/ABIONYX-Pharma-Monthly-Statement-of-Total-Voting-Rights-and-Shares-Forming-the-Companys-Share-Capital","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TT0EK3CzTwNkFXLodF9qywpRX4YLHRHLH85vZjbl0Upn2w4CDySjyJfwpDgstPgVU7GKFFENxyNJq8ddL9F9Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-09-01","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1135500","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1135500","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"7MRO6-Um6qzaHaKC7ELMJRaCdKGAtEp5Eyun9tn6zJwoE7Q0zJ9a65TbcmksfJu4nDXgqLpHYXNFuUe9_o3WBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-09-01","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1135498","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1135498","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SOiI-7Vd1ppuhJJSJbkafec_6wwEtarytGgSuO2LhFhrdX5mLBxHdwvNtulb3mJQe7xMvqZ5WhVbGB90FuxWDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-08-27","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1135094","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1135094","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zsBZC9cH0C6TLv55-Zg5kDJY5fjr7UNibZKT8rHg2f6lHiZIsLsisuFvv2O7S92gkCNnWYTtlhlHCI0GH9g-AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-08-27","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1135092","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1135092","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"q8UBtw7-CLYRLj9XKSbPXHEeUfEpGvJC6d1zyOwROG70i8NViBSgETvFZk5wQU9wL-mVr0RxoDZAQrAkBSj-Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-08-27","event_type":"newswire_release","title":"ABIONYX Pharma Provides an Update on Its Activity and Cash ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260827252824/en/ABIONYX-Pharma-Provides-an-Update-on-Its-Activity-and-Cash-Position-for-the-First-Half-of-2026","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_Xqvt8_bpSvjkobTAUAUt-15i2bQ4x4RsopIE3eXVklhAK5ibapDe5PxWCzj3_pJHYweV2NUXlGCF0KQ7d9KDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-07-16","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C1054","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C1054","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"vy4bJRBNULP8qfcW2rahp7hrkBqo9yskBu1ZMy0h6p-PDVViV4J7rLYPd8l24Gjv5pLNwL-6rC3dKum65iJ7CQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-06-30","event_type":"newswire_release","title":"ABIONYX Pharma change d'échelle suite à la sécurisation des ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260630765233/fr","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qwLZIxZbg9vt_enqcGNXE6yHSU6fQNfwgyCtqzmqB_DqBAis4PhW3NZr9Oivg3fizLz9alsfvIrVg7Dpp0PXDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-06-26","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C0919","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C0919","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Rf8gmjKrONKvjYO7A_LnVhxrYav54uh3330mv3xoE8DGIL1Jpq87yJq12psa8FaKEzvX9fbglgGL-dKYJcoODQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-06-26","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"226C0914","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/226C0914","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lqEWFGH0ts0cCiTMHFuyQYeSpgW6gvzoh-UpXLp2FjXQKjEDd6jIbU8mycTJinqXDFYaZbZ7J5W2krvFDzELDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-06-24","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1122621","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1122621","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rzbUwb2CDoEgqpFJ_KSdLU8xAewSyE82POBgo4C1SHRkRqb-1v4N4VuhiGio7R1dvs59lpjMmqTIfYf3H_F6Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-06-22","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1122081","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1122081","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Bvc6jbBo_SYyFt3KAui49SjmqX8UU4dvbAO7Z_CLjSP_d9uxgQGGDgizJlAElHwuCRy7nRKwIV0FG1TcsgppAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-06-18","event_type":"newswire_release","title":"ABIONYX Pharma Announces the Success of its Financing for a ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260617224761/en/ABIONYX-Pharma-Announces-the-Success-of-its-Financing-for-a-Total-Maximum-Amount-of-EUR-33-M","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"M6E8BqvtsUEqKSoEzpaR0f2prEozGn0Kj5U9KcQcQtMx2FbXvjbAZXFH9zzEaedWN4VETII6QAVjaPvRUZb_Aw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-05-27","event_type":"newswire_release","title":"ABIONYX Pharma Launches Fully Secured Capital Increase with ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260526562890/en/ABIONYX-Pharma-Launches-Fully-Secured-Capital-Increase-with-Preferential-Subscription-Rights-and-Structured-Debt-Financing-for-an-Aggregate-Amount-of-up-to-c.-EUR-33-M","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"nB2Q7bL2iDsm7nD9mj8yivrLOcDMYYQPaC9WPTtOgaBDNsf8McwX_zFQH6dpU51A937XZFcaJwLb6rsAY86AAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-04-08","event_type":"major_holder","title":"ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260408987270/en/ABIONYX-Pharma-Monthly-Statement-of-Total-Voting-Rights-and-Shares-Forming-the-Companys-Share-Capital","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GCZIWdCIMUprEQnhb21CBwMGjuVvzD5PUFMCu_z5MRMEGQTU5Ua3ZOjk5lUmQpzfUBHI5-xKsn0bt4bLajphCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-03-19","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1101863","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1101863","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xWmGSmGklWOzJ4rzwyOIIaj-dBh4o1l3skf1-Y77Hk5XLXNmoUr5DZrhSwX0OLkvrxZYjo9kjyqD22Ck3kOLDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-03-18","event_type":"prospectus","title":"DocumentEnregistrementUniversel [VISA]","reference":"D.26-0099","category":"VISA","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/D.26-0099","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DocumentEnregistrementUniversel; documents 2; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Nn0YB1NvY9KLjVdj4Uw_tRxKpbQTSeHSvuPSSuiXJbmn6huQ2c-1_H_KwHX5k4jzGx1MNaj95bPHFHS4oPaNBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-02-04","event_type":"major_holder","title":"ABIONYX Pharma: Monthly Statement of Total Voting Rights and Shares Forming the Company’s Share Capital","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260204006045/en/ABIONYX-Pharma-Monthly-Statement-of-Total-Voting-Rights-and-Shares-Forming-the-Companys-Share-Capital","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Bu2YdQD4mN70JMmrrnIoC7-cezlizei3Jm07I1TDQUZMiLpi9YCwDylex16twSmU62RHAitCEwfFgb1XUpTeCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-01-27","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2026DD1091182","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2026DD1091182","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"1A02KC3bO_jW3NX2Yq2kyjHfOPB0-IkU7jWUd6xrR1b5AbphEJZbfsh5SvuoiRMkwKu-ccNe7fD59SLqtgDIBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-01-23","event_type":"newswire_release","title":"ABIONYX Pharma Announces Its Financial Calendar for the Year 2026","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260123890011/en/ABIONYX-Pharma-Announces-Its-Financial-Calendar-for-the-Year-2026","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HbNpHKg7FLlbJE3t3ShKkxhKKxHvE4B35dDG_aAHcCQ9UNmeVvnMgMeqDZICNZnjLW44yx0f4KUSFrsgbfnFDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2026-01-07","event_type":"newswire_release","title":"ABIONYX Pharma: Half-Yearly Report on the Liquidity Contract with TP ICAP (Europe) SA","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260107590484/en/ABIONYX-Pharma-Half-Yearly-Report-on-the-Liquidity-Contract-with-TP-ICAP-Europe-SA","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"RSfE3AIWmnAyITct6BCw3HWPni4azQOrQtCisE24LityN8OrI76JvW2yvbRTbTgRUod1uZEydDhiM8NlNqt2Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-12-25","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2025DD1086325","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2025DD1086325","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"eFaXf_zboAG6cGCzaIFbUvubOc_aNhvYrVzee6gv_H2IbRiXdDfjX2ghPMPcidBynmwo4IMZcy32zl57ionQDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-12-19","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2025DD1085381","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2025DD1085381","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GZe8pSfghKwAQdTyGJhL3QlIzov9iw8T99IVRI4PV0qwaGrHoun2J_rOHrVxgdo5vagwiCT8nPUwcpJWduMxDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-12-19","event_type":"directors_dealings","title":"DeclarationDirigeants [DD]","reference":"2025DD1085361","category":"DD","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/2025DD1085361","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types DeclarationDirigeants; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2ObFiyOVOayqXCYKaZ6friQhFlREm0rcS6EO9v-_INBeKHbK40lzF-KSqjIr_l7TVEolgZG5MxAlTS7AIaF5AQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-11-25","event_type":"results","title":"ABIONYX Pharma Reports on Its Business and Cash Position for the Third Quarter of 2025","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251125254534/en/ABIONYX-Pharma-Reports-on-Its-Business-and-Cash-Position-for-the-Third-Quarter-of-2025","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"WG_ITmgzfWiHqFznFzv1u7iLz5mY8QMW-3t1BcW8F6xh7-1p1nrTCdt5IBO0acnvFr3hAZ_WrFf5VXfJgorQBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-11-20","event_type":"newswire_release","title":"ABIONYX Pharma and SEBIA Announce an Exclusive Global ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251120289715/en/ABIONYX-Pharma-and-SEBIA-Announce-an-Exclusive-Global-Strategic-Partnership-to-Transform-Sepsis-Diagnosis","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"g70XPsAuvqCD_-1wKOCt0TCPsVL5sPnfcmtZY3IxYyoMWUt2AHf-9wtYtmU-j4LXRM6_zuPGh9fC8NCSHzxOAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-11-11","event_type":"newswire_release","title":"ABIONYX Pharma Enters Advanced Strategic Discussions with IHU SEPSIS, the World’s First Center Dedicated to Sepsis","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251111036210/en/ABIONYX-Pharma-Enters-Advanced-Strategic-Discussions-with-IHU-SEPSIS-the-Worlds-First-Center-Dedicated-to-Sepsis","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5ZcKJPpphMhAbeF5qyFdOrugj40AfdVsARKZ2-jENQf26pOZxt2kYu8u2qNgq8umjyP55YCMO2xjg8PRkykWAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-10-21","event_type":"newswire_release","title":"ABIONYX Pharma Announces Landmark Validation: A Study Published in NATURE Confirms Genetic Causality of Apolipoprotein A-I (ApoA-I) in Sepsis","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251021992375/en/ABIONYX-Pharma-Announces-Landmark-Validation-A-Study-Published-in-NATURE-Confirms-Genetic-Causality-of-Apolipoprotein-A-I-ApoA-I-in-Sepsis","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"p6085iJ0zro-GdaLDOVQLs81XYoJdThGsVLf4vajxo50NRwWETyrnQy_uWkLhQbJnO7ukbcFnV1Kps6BqXv1AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-10-21","event_type":"newswire_release","title":"ABIONYX Pharma Announces Landmark Validation: A Study Published in NATURE Confirms Genetic Causality of Apolipoprotein A-I (ApoA-I) in Sepsis","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20251021415199/en/ABIONYX-Pharma-Announces-Landmark-Validation-A-Study-Published-in-NATURE-Confirms-Genetic-Causality-of-Apolipoprotein-A-I-ApoA-I-in-Sepsis","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"c1DFOmgdJpn8NjGwoFktekVhOZtbNWhRYz7A2V6r74halZmdJiIp5GDJnTkzaXD-8V_Am0_SafivRygMzqyBAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-10-03","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"225C1690","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1690","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Ss7GaTLXfcgzAB4fO_D2pFRfyPbS--sMl36I0XvZPchzh9cC-zvtTbXD_EJlEbDl8jf95gP5iPsfeq7HjyyvDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"fr-cm-kg/XPAR/FR0012616852","date":"2025-10-03","event_type":"regulatory_filing","title":"Declarations [SPDE]","reference":"225C1687","category":"SPDE","language":"fr","wire":"AMF BDIF","source":"AMF BDIF regulatory information","url":"https://bdif.amf-france.org/#/information/225C1687","read_by":"AMF BDIF regulatory-information database (per filer token)","detail":"types Declarations; documents 1; filer ABIONYX PHARMA","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"k5pUQuyPQwF1vBLFRroFXYImEE5yocrzrNLgH1uPiNG67r9hVQhPWRr1VQ5L8BeUtsl7R8ieWdDavGrCwOKjAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}